John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Curtiss-Wright
CW
$23.5B
| $37.6M | 0.08% |
118,426
-21,263
| -15% | -$7.17M |
|
277
Franklin Templeton
BEN
$17.4B
| $37.4M | 0.08% |
1,941,028
-994,264
| -34% | -$19.9M |
|
278
Digital Realty Trust
DLR
$70.5B
| $37.2M | 0.08% |
+259,798
| New | +$42.3M |
|
279
Genmab
GMAB
$20.6B
| $37.2M | 0.08% |
1,899,766
+193,402
| +11% | +$4.06M |
|
280
Avery Dennison
AVY
$13.9B
| $37.1M | 0.08% |
208,224
+137,592
| +195% | +$25.3M |
|
281
FTAI Aviation
FTAI
$21.5B
| $36.8M | 0.08% |
331,508
-513,264
| -61% | -$60.6M |
|
282
Credo Technology Group
CRDO
$43B
| $36.8M | 0.08% |
915,872
-599,396
| -40% | -$37.3M |
|
283
Unity
U
$20.7B
| $36.7M | 0.08% |
1,873,257
+849,727
| +83% | +$19.2M |
|
284
PUT
Starwood Property Trust
STWD
$6.06B
| $36.7M | 0.08% |
1,855,000
-89,300
| -5% | -$1.75M |
|
285
Advance Auto Parts
AAP
$2.57B
| $36.7M | 0.08% |
+935,000
| New | +$40.1M |
|
|
B
286
Barrick Mining
B
$78.3B
| $36.6M | 0.08% |
1,884,743
-815,863
| -30% | -$14.3M |
|
287
Old Dominion Freight Line
ODFL
$42.8B
| $36.5M | 0.08% |
220,816
-246,117
| -53% | -$44.7M |
|
288
Illumina
ILMN
$33.1B
| $36.5M | 0.08% |
459,537
-274,381
| -37% | -$29.7M |
|
289
British American Tobacco
BTI
$121B
| $36M | 0.08% |
869,950
+46,197
| +6% | +$1.82M |
|
290
PBF Energy
PBF
$8.72B
| $35.7M | 0.08% |
1,872,507
+226,923
| +14% | +$5.65M |
|
291
iShares Biotechnology ETF
IBB
$10.7B
| $35.5M | 0.08% |
277,807
+43,200
| +18% | +$5.86M |
|
292
Lumen
LUMN
$6.13B
| $35.5M | 0.08% |
9,062,878
+206,040
| +2% | +$1.03M |
|
293
Amdocs
DOX
$6.41B
| $35.5M | 0.08% |
387,486
+69,753
| +22% | +$6.09M |
|
294
PUT
Burlington
BURL
$20.6B
| $35.4M | 0.08% |
148,600
-45,100
| -23% | -$11.7M |
|
295
Bruker
BRKR
$9.07B
| $35.3M | 0.08% |
844,771
+328,539
| +64% | +$17.1M |
|
296
SPDR Gold Trust
GLD
$152B
| $35.2M | 0.08% |
+122,109
| New | +$32.3M |
|
297
Sarepta Therapeutics
SRPT
$1.98B
| $35.2M | 0.08% |
550,880
+475,826
| +634% | +$50.1M |
|
298
Hormel Foods
HRL
$13.1B
| $34.8M | 0.07% |
1,123,901
-929,259
| -45% | -$27.6M |
|
299
Arch Capital
ACGL
$33.9B
| $34.5M | 0.07% |
359,135
+251,668
| +234% | +$23.2M |
|
300
Waters Corp
WAT
$40.4B
| $34.4M | 0.07% |
93,274
-17,987
| -16% | -$6.96M |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.